Queens Hospital Cancer Center — Jamaica, New York

Queens Hospital Cancer Center is a clinical research site located in Jamaica, New York, United States 11432.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

Queens Hospital Cancer Center has participated in 5 clinical trials with 3 currently active.

Therapeutic areas: Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer, Breast Cancer, Sickle Cell Disease.

Sponsors: Hoffmann-La Roche, Celcuity Inc, Fulcrum Therapeutics.

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Queens Hospital Cancer Center?

Queens Hospital Cancer Center has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Queens Hospital Cancer Center conducted?

Queens Hospital Cancer Center has 5 clinical trials on record, with 3 currently active. Their work covers Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer, Breast Cancer, Sickle Cell Disease.

Is Queens Hospital Cancer Center accredited by Crixeo Health?

Queens Hospital Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Queens Hospital Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.